Wambolt & Associates’s Corteva CTVA Stock Holding History

Wambolt & Associates’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$2.29M	Sell	30,457 -1,750	-5%	-$117K	0.77%	40
2025 Q1	$2.05M	Buy	32,207 +1,225	+4%	+$75.7K	0.69%	52
2024 Q4	$1.76M	Sell	30,982 -5,770	-16%	-$341K	0.56%	60
2024 Q3	$2.13M	Buy	36,752 +3,230	+10%	+$176K	0.58%	57
2024 Q2	$1.78M	Buy	33,522 +4,799	+17%	+$264K	0.52%	61
2024 Q1	$1.66M	Buy	28,723 +8,067	+39%	+$417K	0.5%	66
2023 Q4	$990K	Buy	20,656 +4,543	+28%	+$217K	0.32%	105
2023 Q3	$806K	Buy	16,113 +5,392	+50%	+$286K	0.29%	121
2023 Q2	$614K	Buy	10,721 +2,897	+37%	+$169K	0.22%	142
2023 Q1	$477K	Buy	+7,824	New	+$478K	0.17%	166

Other funds holding CTVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IFP

Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return

Wambolt & Associates's CTVA Position: Q2 2025 in Review

Wambolt & Associates reduced its Corteva (CTVA) stake by 5.4% in Q2 2025, selling an estimated $117K and leaving 30,457 shares worth $2.29M. The position accounts for 0.77% of the portfolio, ranked #40.

Wambolt & Associates first reported a position in CTVA in Q1 2023 and has held it in 10 quarters since. 1,401 funds tracked by Wall St. Rank hold CTVA as of Q2 2025.

Wambolt & Associates held 30,457 shares of Corteva worth $2.29M as of Q2 2025.
Wambolt & Associates sold 1,750 Corteva shares in Q2 2025, an estimated $117K.
Corteva made up 0.77% of Wambolt & Associates's portfolio in Q2 2025, its #40 holding.
Wambolt & Associates first reported a position in Corteva in Q1 2023 and has held it in 10 quarters since.
1,401 funds tracked by Wall St. Rank held Corteva as of Q2 2025.

Based on Wambolt & Associates's 13F filing for Q2 2025, filed 13 Aug 2025.